Panel Discussion

Four visionary leaders from science, industry and venture capital discussed the near-term opportunities to diagnose, treat and cure cancer. This powerful gathering of some of the best minds in cancer research included:

Susan Desmond-Hellmann, UCSF’s chancellor-elect and former president of product development at Genentech.

J. Craig Venter, one of the premier scientists of the 21st century and the pioneer responsible for sequencing the human genome.

Frank McCormick, director of UCSF’s Helen Diller Family Comprehensive Cancer Center and internationally renowned cancer researcher.

Brook Byers, partner at Kleiner Perkins Caufield & Byers, and a venture capital investor, entrepreneur and company builder since 1972.

For the Media